Background-A non-invasive marker is needed to identify patients with significant gastrointestinal injury due to non-steroidal anti-inflammatory drugs. Gastrointestinal permeability to sucrose has been suggested as such a test. Ains-To assess the utility of sucrose permeability as a marker of gastroduodenal mucosal injury after single and multiple doses of aspirin, to identify the site of increased sucrose permeability, to explore the relation between sucrose permeability and endoscopic findings, and to evaluate whether Helicobacter pylori infection influenced gastroduodenal sucrose permeability. Methods-After a fasting urine was obtained, 500 ml of a solution containing 100 g of sucrose was ingested. Urine was collected for five hours and assayed for sucrose by high performance liquid chromatography. Sucrose permeability was also assessed 20 minutes after ingestion of 650 mg of aspirin and eight to 12 hours after a 72 hour course of 650 mg aspirin four times a day. The site of increased permeability was identified after pyloric occlusion with a double balloon tube.
and to evaluate whether Helicobacter pylori infection influenced gastroduodenal sucrose permeability. Methods-After a fasting urine was obtained, 500 ml of a solution containing 100 g of sucrose was ingested. Urine was collected for five hours and assayed for sucrose by high performance liquid chromatography. Sucrose permeability was also assessed 20 minutes after ingestion of 650 mg of aspirin and eight to 12 hours after a 72 hour course of 650 mg aspirin four times a day. The site of increased permeability was identified after pyloric occlusion with a double balloon tube.
Results-Thirty seven healthy volunteers participated. Sucrose permeability (mean (SEM)) increased after both single (195.2 (27) mg and multiple (196. 4 (31) mg) doses of aspirin compared with baseline (53.7 (10) We began our studies with the notion that the published conclusion possibly erred as they examined sucrose permeability 20 minutes after aspirin ingestion, a time when the gastric mucosal potential difference is considerably depressed and severe surface damage is present.±9 Control experiments with multiple doses of aspirin administration at a time when the mucosal potential difference is normal but the mucosa is visibly damaged were not presented. Experiments two or more hours after aspirin administration were important controls to confirm that the abnormalities in permeability were not simply due to acute surface damage. With longterm aspirin administration, the gastric potential difference still falls immediately after aspirin administration despite the fact that the gastric mucosa becomes resistant to the development of endoscopically grossly visible lesions.9-1 Because NSAID damage extends into the proximal small intestine, it was also possible that the site of increased permeability was not the stomach but rather the proximal small intestine. We therefore set out to confirm their original findings and extend those observations to multiple dose aspirin administration as well as to test whether the stomach was the major site of increased sucrose permeability. Finally, as they had not taken into account the possible confounding effect of gastric infection with Helicobacter pylori, we also evaluated the effect of Hpylori infection on sucrose permeability in the presence and absence of aspirin.
Methods
Thirty seven asymptomatic healthy volunteers participated in one or more phases of the study. All were over 18 years of age, and none had previous gastrointestinal surgery, diabetes, symptomatic gastro-oesophageal reflux disease, renal insufficiency, any use of non-steroidal anti-inflammatory agents, steroids, potassium, antibiotics, histamine 2 antagonists, proton pump inhibitors, bismuth or excess alcohol consumption during the previous 30 days. Written informed consent was obtained. The protocol of this study was approved by the local Human Subjects Review Committees.
Gastroduodenal sucrose permeability Gastroduodenal permeability was assessed by the gastroduodenal sucrose permeability test. The first morning voided urine specimen was collected from all patients (fasting) prior to testing. The subjects then ingested 500 ml of a solution containing 100 g of sucrose in water. Urine was collected for five hours. During the collection subjects were encouraged to drink water but to abstain from drinking coffee or anything with sugar. Only water was permitted during the first two hours of the collection. Urine samples were immediately refrigerated and frozen at -20°C within 24 hours. Urine sucrose was measured by high performance liquid chromatography.
Gastric sucrose permeability The gastric contribution to sucrose permeability was assessed by the gastric sucrose permeability test utilising a double balloon tube for pyloric occlusion. Endoscopy was performed after an overnight fast using only topical oropharyngeal anaesthesia. The gastroduodenal mucosa was evaluated with attention to the location and number of epithelial haemorrhages, erosions or ulcers, or all three. A 400 cm length flexible tipped piano guidewire (Microvasive, Natick, MA) was introduced into the working channel of the endoscope and advanced into the second portion of duodenum. The endoscope was withdrawn. A multilumen, double balloon orogastric tube was passed over the wire. Under endoscopic view, and assistance, the distal balloon was positioned in the duodenal bulb, and inflated. The proximal balloon was then inflated forming a gastric outlet seal by apposition of the balloons. The endoscope was withdrawn and an 18 French Salem Sump orogastric tube (Argyle, St Louis, MO) was passed orally into the stomach.
Five hundred millilitres of a sucrose solution containing 100 g of sucrose was instilled in the stomach through the orogastric tube. After 30 minutes, the solution was removed and the volume recovered was measured to assess adequate recovery, defined as greater than 90%. The stomach was then rinsed three times with 500 ml of room temperature tap water. In four patients, an aliquot of the total collection was obtained, refrigerated, and frozen at -20°C to determine the amount of sucrose recovered. Urine was collected for the following five hours as previously described.
Aspirin and H pylori induced injury Mucosal injury was evaluated 20 minutes after the oral administration of 650 mg of aspirin (single dose). As the greatest degree of endoscopically visible mucosal injury has been shown to occur after three days of continuous aspirin administration,9 aspirin was continued at the dose of 650 mg four times daily for three days. Mucosal injury was assessed eight to 12 hours after the final dose of aspirin (multiple dose). No biopsy specimens were taken to assess histology or to confirm H pylori status because of possible effects on sucrose permeability.
H pylori status was determined by serum ELISA (HM-CAP, EPI, Westbury, NY) in 28 subjects who received aspirin to assess whether the presence of H pylori infection influenced sucrose permeability. This assay has been shown to have a sensitivity of greater than 95% for detecting Hpylori infection in patients without history of antibiotic or proton pump inhibitor use. The endoscopist was blinded to the Hpylori infection status of the subjects. (Fig 3) .
Statistics

Effect of H pylori infection
To assess the contribution of H pylori to changes in gastric mucosal integrity, the gastroduodenal sucrose test was performed in a group of 28 subjects (18 without H pylori infection) without aspirin (baseline) and following single dose aspirin. Endoscopic assessment of mucosal injury and the gastroduodenal sucrose test was also performed in 19 subjects (12 without H pylori infection) after multiple dose aspirin. No sucrose was detected in fasting urine samples. Baseline values were similar between the Hpylori infected and uninfected volunteers (Fig 4) . Mean urinary sucrose recovery increased after single and meability increased in association with aspirin induced mucosal injury. In our population, the mean urinary sucrose recovery in the absence of aspirin was less than previously reported (53.7 mg compared with 110 mg).3 Nevertheless, a fourfold increase in sucrose recovery after aspirin administration was seen in both studies. We also extended the previous findings to three days of aspirin administration.
We confirmed that the increase in sucrose permeability was site specific. We hypothesised the increase in aspirin induced sucrose permeability was probably the result of small intestinal sucrose absorption and that obstruction of the stomach with a balloon would abolish the increase in sucrose absorption. However, we found aspirin induced a fourfold increase in sucrose permeability even when the duodenum was occluded suggesting that the stomach is the primary site of increased intestinal permeability. It is unknown whether the trauma associated with placement of the pyloric occlusion balloon also increased mucosal injury and contributed to the increased sucrose recovery. As sucrose empties from the stomach during the standard sucrose permeability test but does not during balloon pyloric occlusion, and the balloon displaces the mass of sucrose solution, the mucosal surface area exposed to sucrose was likely to have been much greater during the balloon test. It is therefore not clear whether increased surface area or longer duration of contact is the most important factor related to increased sucrose absorption during balloon pyloric occlusion.
Tests with higher concentrations of sucrose and larger volumes of solution are needed to tackle this question. Sucrose recovery after single and multiple dose aspirin ingestion were similarly increased suggesting that the increase in sucrose permeability was not due to generalised leakiness of the gastric mucosa associated with the pronounced fall in mucosal potential difference and widespread surface damage seen immediately after injury with aspirin and alcohol (Fig 1) . The variability in the aspirin induced changes among subjects suggest that some people may be more sensitive to the affects of aspirin. The increase in sucrose permeability after multiple dose aspirin administration did not correlate with the number of erosions and haemorrhages. This finding in a group of healthy volunteers suggests the increase in sucrose permeability after a 72 hour course of aspirin is related to microscopic, and not macroscopic changes. Prospective, randomised trials evaluating sucrose permeability in a group of longterm NSAID users is needed to determine the clinical utility of this test.
H pylori infection did not seem to affect gastric mucosal permeability to sucrose either at baseline or after the administration of single or multiple doses of aspirin. Furthermore, as previously reported, the gastric mucosa of our group of asymptomatic H pylori infected people seemed less susceptible to mucosal injury. 12-16 Despite fewer number of erosions and epithelial haemorrhages, the H pylori group had similar mean sucrose recovery after aspirin ingestion than the uninfected group.
Recently, the sucrose test was suggested as being able to predict endoscopic mucosal injury.17 In a group of 187 patients requiring endoscopic evaluation, or taking NSAIDs, increased sucrose permeability was associated with severe gastritis and gastric ulcers but not with mild gastritis or duodenal disease. In that study, the sensitivity for detecting mild gastritis, duodenitis, severe gastritis, and gastric ulcers was 16%, 29%, and 84%, respectively. The specificity for predicting an abnormal endoscopy was 96%. That analysis included patients with previous ulcer history and those requiring urgent endoscopy. Of interest, our study used the same endoscopic scoring system and we found that the sensitivity of sucrose permeability for mild gastritis (n= 12), duodenitis (n= 14), and severe gastritis (n=6) was similar; 17%, 29%, and 67%, respectively. No ulcers were seen in our population.
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